GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish ...

Certified kitchen knife nerd Scott Heimendinger used a robot arm on multiple chef’s knives to collect 100,000 data points ...

An amicus brief from the Electronic Frontier Foundation asks an appeals court to consider Watergate-era privacy protections ...

In uncertain times, founders must be bold and adaptable in how they position and promote their brands, given tightened ...

This Mars rock is up for auction at Sotheby's in New York City this week, which is why it's currently on display in the Upper ...

A group of bipartisan women senators is pushing for more diversity in crash test dummies, hoping it will help solve the problem. "Whether driving or as passengers, we wanna make sure that women are ...

North Carolina Attorney General Jeff Jackson successfully ensures 23-and-Me customers’ sensitive genetic information remains ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

A new asset-testing guideline for reinsurance deals will result in no direct action, even if regulators uncover negative numbers.

Automation and digitalization in heavy plate testing improve efficiency and accuracy, ensuring these vital materials meet the demands of diverse applications.

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full analysis here.

Offensive security tools, which are designed to proactively identify threats and vulnerable attack vectors before they occur, have long been exploited by threat actors. AI is, unfortunately, ...